Results of superior vena cava resection for lung cancer - Analysis of prognostic factors

被引:60
|
作者
Spaggiari, L
Magdeleinat, P
Kondo, H
Thomas, P
Leon, ME
Rollet, G
Regnard, JF
Tsuchiya, R
Pastorino, U
机构
[1] European Inst Oncol, Dept Thorac Surg, I-20141 Milan, Italy
[2] Hop Hotel Dieu, Dept Thorac Surg, F-75181 Paris, France
[3] Natl Canc Ctr, Dept Thorac Surg, Tokyo 104, Japan
[4] St Marguerite Univ Hosp, Dept Thorac Surg, Marseille, France
[5] European Inst Oncol, Dept Biostat, Milan, Italy
关键词
lung cancer; superior vena cava; surgery; extended resection; T4; mediastinal surgery; vascular surgery;
D O I
10.1016/j.lungcan.2003.11.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims: The benefits of superior vena cava (SVC) resection for lung cancer remain controversial. Data obtained in four international centers were analyzed in order to identify prognostic factors and thus guide in future patient selection. Materials and methods: Retrospective study. Prognostic factors were examined by logistic regression for postoperative morbidity/mortality using the Kaplan-Meier method (log rank test) and the Cox proportional-hazard model for survival. Results: From 1963 to 2000, 109 patients underwent SVC resection. Induction treatment was given to 23 (21%) patients. The SVC was resected for T involvement in 78 (72%) cases and for N involvement in 31 (28%) cases. Fifty-five (50.5%) patients underwent pneumonectomy (20 with carinal resection), while the remaining underwent lobar resections. Prosthetic SVC replacement was performed in 28 (26%) patients; partial resection with running suture (53%), vascular stapler (13%), or patch (7%) was performed in 80 patients; 1 patient did not undergo reconstruction. Pathological examination identified direct involvement (T4) in 66 (60%) patients and N2 disease in 55 (50%) patients. Major postoperative morbidity and mortality were 30 and 12%, respectively. Median intensive care unit stay was 3 days, while median hospital stay was 16 days. Five-year survival was at 21%, with median survival at 11 months. In multiple regression analysis, induction treatment was associated with an increased risk of major complications (P = 0.016). None of the factors assessed demonstrated an association with postoperative death. In multivariate survival analysis, both pneumonectomy and complete resection of the SVC with prosthetic replacement were associated with a significant increased risk of death (P = 0.0013 and 0.014, respectively). Conclusions: The radical resection of lung cancer involving the SVC may result in a permanent cure in carefully selected patients. The type of pulmonary resection (i.e., pneumonectomy) and the type of SVC resection (i.e., complete resection with prosthetic replacement) are the prognostic factors with the greatest adverse effect on survival. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:339 / 346
页数:8
相关论文
共 50 条
  • [1] Superior Vena Cava Resection and Reconstruction with Resection of Primary Lung Cancer and Mediastinal Tumor
    Cusimano, Robert James
    Shamji, Farid M.
    THORACIC SURGERY CLINICS, 2021, 31 (04) : 463 - 468
  • [2] Superior Vena Caval Resection in Lung Cancer
    Lee, Dong-Seok D.
    Flores, Raja M.
    THORACIC SURGERY CLINICS, 2014, 24 (04) : 441 - +
  • [3] EXTENDED OPERATION FOR LUNG-CANCER INVADING THE SUPERIOR VENA-CAVA
    THOMAS, P
    MAGNAN, PE
    MOULIN, G
    GIUDICELLI, R
    FUENTES, P
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1994, 8 (04) : 177 - 182
  • [4] Superior vena cava resection with prosthetic replacement for non-small cell lung cancer: long-term results of a multicentric study
    Spaggiari, L
    Thomas, P
    Magdeleinat, P
    Kondo, H
    Rollet, G
    Regnard, JF
    Tsuchiya, R
    Pastorino, U
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2002, 21 (06) : 1080 - 1086
  • [5] Superior Vena Cava Resection and Prosthetic Replacement for NSCLC: Is It Worthwhile?
    Chenesseau, J.
    Mitilian, D.
    Mussot, S.
    Mercier, O.
    Fabre, D.
    Fadel, E.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S896 - S896
  • [6] Superior vena cava reconstruction using heterologous pericardial tube after extended resection for lung cancer
    Spaggiari, L
    Veronesi, G
    D'Aiuto, M
    Tosoni, A
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2004, 26 (03) : 649 - 651
  • [7] Surgical Resection of an Intravascular Lipoma of the Superior Vena Cava
    Cohen-Mussali, Salomon
    Leon, Monica
    Rey-Rodriguez, Alejandro
    Canalizo, Eduardo
    Yebra-Lopez, Adrian
    Gomez-Gonzalez, Mauricio Damian
    Ramirez-Cerda, Claudio
    Valdes-Flores, Jaime
    VASCULAR AND ENDOVASCULAR SURGERY, 2023, 57 (02) : 169 - 174
  • [8] Superior vena cava resection and reconstruction in mediastinal tumors and benign diseases
    Kaba, Erkan
    Ozkan, Berker
    Ozyurtkan, Mehmet Oguzhan
    Ayalp, Kemal
    Toker, Alper
    TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 26 (01): : 99 - 107
  • [9] Extended Resection of Non-small Cell Lung Cancer with Superior Vena Cava Involvement: A Systematic Review and Meta-analysis
    Hamouri, S.
    Syaj, S.
    Akhdar, M.
    Al-Kraimeen, L. M.
    Tawalbeh, R.
    Hecker, E.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S300 - S300
  • [10] Superior vena cava prosthetic replacement for non-small cell lung cancer: is it worthwhile?
    Chenesseau, Josephine
    Mitilian, Delphine
    Sharma, Gaurav
    Mussot, Sacha
    Boulate, David
    Haulon, Stephan
    Fabre, Dominique
    Mercier, Olaf
    Fadel, Elie
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2021, 60 (05) : 1195 - 1200